|
1）Bekheirnia MR, Reed B, Gregory MC, et al. Genotype-phenotype correlation in X-linked Alport syndrome. J Am Soc Nephrol. 2010; 21: 876-83
|
|
|
|
2）Gross O, Netzer KO, Lambrecht R, et al. Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling. Nephrol Dial Transplant. 2002; 17: 1218-27
|
|
|
|
|
|
3）Jais JP, Knebelmann B, Giatras I, et al. X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol. 2000; 11: 649-57
|
|
|
|
|
|
4）Hashimura Y, Nozu K, Kaito H, et al. Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV alpha5 chain. Kidney Int. 2014; 85 1208-13
|
|
|
|
|
|
5）Kaneko K, Tanaka S, Hasui M, et al. A family with X-linked benign familial hematuria. Pediatr Nephrol. 2010; 25: 545-8
|
|
|
|
|
|
6）Krol RP, Nozu K, Nakanishi K, et al. Somatic mosaicism for a mutation of the COL4A5 gene is a cause of mild phenotype male Alport syndrome. Nephrol Dial Transplant. 2008; 23: 2525-30
|
|
|
|
|
|
7）Nozu K, Vorechovsky I, Kaito H, et al. X-linked Alport syndrome caused by splicing mutations in COL4A5. Clin J Am Soc Nephrol. 2014; 9: 1958-64
|
|
|
|
|
|
8）Kashtan CE. Alport syndrome and thin glomerular basement membrane disease. J Am Soc Nephrol. 1998; 9: 1736-50
|
|
|
|
|